Metacognitive Therapy for Depression: A 3-Year Follow-Up Study Assessing Recovery, Relapse, Work Force Participation, and Quality of Life
A major challenge in the treatment of depression has been high relapse rates following treatment. The current study reports results from a 3-year follow-up of patients treated with metacognitive therapy (MCT). Thirty-four of the 39 patients enrolled in the original study attended assessment (partici...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2019-12-01
|
| Series: | Frontiers in Psychology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/article/10.3389/fpsyg.2019.02908/full |
| _version_ | 1818136368931405824 |
|---|---|
| author | Stian Solem Leif Edward Ottesen Kennair Roger Hagen Audun Havnen Hans M. Nordahl Hans M. Nordahl Adrian Wells Adrian Wells Odin Hjemdal |
| author_facet | Stian Solem Leif Edward Ottesen Kennair Roger Hagen Audun Havnen Hans M. Nordahl Hans M. Nordahl Adrian Wells Adrian Wells Odin Hjemdal |
| author_sort | Stian Solem |
| collection | DOAJ |
| description | A major challenge in the treatment of depression has been high relapse rates following treatment. The current study reports results from a 3-year follow-up of patients treated with metacognitive therapy (MCT). Thirty-four of the 39 patients enrolled in the original study attended assessment (participation rate of 87%). There were large reductions in symptoms of depression, anxiety, interpersonal problems, and worry, as well as metacognitive beliefs. Three patients fulfilled diagnostic criteria for axis-I disorders: one with depression and two with generalized anxiety disorder. Sixty percent had not experienced any new depressive episodes in the 3-year follow-up period, and the static relapse rates were low (11–15%). Recovery rates ranged from 69 to 97% depending upon the four different criteria used. Nevertheless, 26% had sought out treatment for depression or other psychological difficulties. Most patients (70%) had experienced negative life events in the follow-up period, but these events did not influence current depression severity. Return to work outcomes were encouraging, as eight out of 13 patients that had been on benefits were no longer receiving benefits. Life satisfaction ratings showed mean scores around 70 (on a 0–100 scale) and showed a moderate to strong negative correlation with depression severity. In conclusion, MCT appears to be promising with respect to long-term effect. Randomized controlled trials should investigate if the long-term effect of MCT surpasses that of other evidence-based treatments for depression. |
| first_indexed | 2024-12-11T09:39:18Z |
| format | Article |
| id | doaj.art-d2dcb0043e1e4853ba937a45d5d5d7a1 |
| institution | Directory Open Access Journal |
| issn | 1664-1078 |
| language | English |
| last_indexed | 2024-12-11T09:39:18Z |
| publishDate | 2019-12-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Psychology |
| spelling | doaj.art-d2dcb0043e1e4853ba937a45d5d5d7a12022-12-22T01:12:44ZengFrontiers Media S.A.Frontiers in Psychology1664-10782019-12-011010.3389/fpsyg.2019.02908506301Metacognitive Therapy for Depression: A 3-Year Follow-Up Study Assessing Recovery, Relapse, Work Force Participation, and Quality of LifeStian Solem0Leif Edward Ottesen Kennair1Roger Hagen2Audun Havnen3Hans M. Nordahl4Hans M. Nordahl5Adrian Wells6Adrian Wells7Odin Hjemdal8Department of Psychology, Norwegian University of Science and Technology, Trondheim, NorwayDepartment of Psychology, Norwegian University of Science and Technology, Trondheim, NorwayDepartment of Psychology, Norwegian University of Science and Technology, Trondheim, NorwayDepartment of Psychology, Norwegian University of Science and Technology, Trondheim, NorwayDepartment of Mental Health, Norwegian University of Science and Technology (NTNU), Trondheim, NorwayDivision of Psychiatry, St. Olavs Hospital, Nidaros Distriktspsykiatriske Senter (DPS), Trondheim, NorwayFaculty of Biology, Medicine and Health, School of Psychological Sciences, Manchester Academic Health Science Centre, The University of Manchester, Manchester, United KingdomGreater Manchester Mental Health NHS Trust, Prestwich, United KingdomDepartment of Psychology, Norwegian University of Science and Technology, Trondheim, NorwayA major challenge in the treatment of depression has been high relapse rates following treatment. The current study reports results from a 3-year follow-up of patients treated with metacognitive therapy (MCT). Thirty-four of the 39 patients enrolled in the original study attended assessment (participation rate of 87%). There were large reductions in symptoms of depression, anxiety, interpersonal problems, and worry, as well as metacognitive beliefs. Three patients fulfilled diagnostic criteria for axis-I disorders: one with depression and two with generalized anxiety disorder. Sixty percent had not experienced any new depressive episodes in the 3-year follow-up period, and the static relapse rates were low (11–15%). Recovery rates ranged from 69 to 97% depending upon the four different criteria used. Nevertheless, 26% had sought out treatment for depression or other psychological difficulties. Most patients (70%) had experienced negative life events in the follow-up period, but these events did not influence current depression severity. Return to work outcomes were encouraging, as eight out of 13 patients that had been on benefits were no longer receiving benefits. Life satisfaction ratings showed mean scores around 70 (on a 0–100 scale) and showed a moderate to strong negative correlation with depression severity. In conclusion, MCT appears to be promising with respect to long-term effect. Randomized controlled trials should investigate if the long-term effect of MCT surpasses that of other evidence-based treatments for depression.https://www.frontiersin.org/article/10.3389/fpsyg.2019.02908/fulldepressionmetacognitive therapymetacognitionlong-term follow-uprecoveryrelapse prevention |
| spellingShingle | Stian Solem Leif Edward Ottesen Kennair Roger Hagen Audun Havnen Hans M. Nordahl Hans M. Nordahl Adrian Wells Adrian Wells Odin Hjemdal Metacognitive Therapy for Depression: A 3-Year Follow-Up Study Assessing Recovery, Relapse, Work Force Participation, and Quality of Life Frontiers in Psychology depression metacognitive therapy metacognition long-term follow-up recovery relapse prevention |
| title | Metacognitive Therapy for Depression: A 3-Year Follow-Up Study Assessing Recovery, Relapse, Work Force Participation, and Quality of Life |
| title_full | Metacognitive Therapy for Depression: A 3-Year Follow-Up Study Assessing Recovery, Relapse, Work Force Participation, and Quality of Life |
| title_fullStr | Metacognitive Therapy for Depression: A 3-Year Follow-Up Study Assessing Recovery, Relapse, Work Force Participation, and Quality of Life |
| title_full_unstemmed | Metacognitive Therapy for Depression: A 3-Year Follow-Up Study Assessing Recovery, Relapse, Work Force Participation, and Quality of Life |
| title_short | Metacognitive Therapy for Depression: A 3-Year Follow-Up Study Assessing Recovery, Relapse, Work Force Participation, and Quality of Life |
| title_sort | metacognitive therapy for depression a 3 year follow up study assessing recovery relapse work force participation and quality of life |
| topic | depression metacognitive therapy metacognition long-term follow-up recovery relapse prevention |
| url | https://www.frontiersin.org/article/10.3389/fpsyg.2019.02908/full |
| work_keys_str_mv | AT stiansolem metacognitivetherapyfordepressiona3yearfollowupstudyassessingrecoveryrelapseworkforceparticipationandqualityoflife AT leifedwardottesenkennair metacognitivetherapyfordepressiona3yearfollowupstudyassessingrecoveryrelapseworkforceparticipationandqualityoflife AT rogerhagen metacognitivetherapyfordepressiona3yearfollowupstudyassessingrecoveryrelapseworkforceparticipationandqualityoflife AT audunhavnen metacognitivetherapyfordepressiona3yearfollowupstudyassessingrecoveryrelapseworkforceparticipationandqualityoflife AT hansmnordahl metacognitivetherapyfordepressiona3yearfollowupstudyassessingrecoveryrelapseworkforceparticipationandqualityoflife AT hansmnordahl metacognitivetherapyfordepressiona3yearfollowupstudyassessingrecoveryrelapseworkforceparticipationandqualityoflife AT adrianwells metacognitivetherapyfordepressiona3yearfollowupstudyassessingrecoveryrelapseworkforceparticipationandqualityoflife AT adrianwells metacognitivetherapyfordepressiona3yearfollowupstudyassessingrecoveryrelapseworkforceparticipationandqualityoflife AT odinhjemdal metacognitivetherapyfordepressiona3yearfollowupstudyassessingrecoveryrelapseworkforceparticipationandqualityoflife |